Update of recent studies in chronic myeloid leukemia

被引：0
|
作者：
Karen Seiter
机构：
[1] New York Medical College,Division of Hematology and Oncology
来源：
Journal of Hematology & Oncology | / 2卷 / Suppl 1期
关键词：
Imatinib; Chronic Myeloid Leukemia; Dasatinib; Nilotinib; Event Free Survival;
D O I：
10.1186/1756-8722-2-S1-A2
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] An Update on the Management of Advanced Phase Chronic Myeloid Leukemia
    Short, Nicholas J.
    Senapati, Jayastu
    Jabbour, Elias
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (6) : 234 - 242
  • [32] Modern therapy of chronic myeloid leukemia
    Leitner, A. A.
    Hehlmann, R.
    INTERNIST, 2011, 52 (02): : 209 - 217
  • [33] Dasatinib for the treatment of chronic myeloid leukemia
    Fullmer, Amber
    Kantarjian, Hagop
    Cortes, Jorge
    Jabbour, Elias
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (03) : 253 - 260
  • [34] Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
    Ross, David M.
    Masszi, Tamas
    Gomez Casares, Maria Teresa
    Hellmann, Andrzej
    Stentoft, Jesper
    Conneally, Eibhlin
    Garcia-Gutierrez, Valentin
    Gattermann, Norbert
    le Coutre, Philipp D.
    Martino, Bruno
    Saussele, Susanne
    Giles, Francis J.
    Radich, Jerald P.
    Saglio, Giuseppe
    Deng, Weiping
    Krunic, Nancy
    Bedoucha, Veronique
    Gopalakrishna, Prashanth
    Hochhaus, Andreas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (05) : 945 - 954
  • [35] Dasatinib in the Treatment of Chronic Myeloid Leukemia
    Gora-Tybor, Joanna
    Robak, Tadeusz
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (01) : 99 - 105
  • [36] Chronic Myeloid Leukemia: Overview of New Agents and Comparative Analysis
    Preetesh Jain
    Hagop Kantarjian
    Jorge Cortes
    Current Treatment Options in Oncology, 2013, 14 : 127 - 143
  • [37] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
    Tiribelli, Mario
    Eskazan, Ahmet Emre
    ONCOLOGY AND THERAPY, 2019, 7 (02) : 95 - 100
  • [38] PHARMACOECONOMIC ANALYSIS OF CHRONIC MYELOID LEUKEMIA REMISSION WITHOUT TREATMENT
    Shuvaev, V. A.
    Abdulkadyrov, K. M.
    Turkina, A. G.
    Martynkevich, I. S.
    Chelysheva, E. Yu
    Fominykh, M. S.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (04): : 14 - 20
  • [39] BUDGET IMPACT ANALYSIS OF CHRONIC MYELOID LEUKEMIA TREATMENT IN BULGARIA
    Savova, Alexandra
    Kamusheva, Maria
    Georgieva, Svetla
    Stoimenova, Assena
    Petrova, Guenka
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2013, 27 (01) : 3595 - 3598
  • [40] Chronic Myeloid Leukemia: Overview of New Agents and Comparative Analysis
    Jain, Preetesh
    Kantarjian, Hagop
    Cortes, Jorge
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 127 - 143
12345